20250327_SILO_Laporan Informasi dan Fakta Material_31871621_lamp3.pdf

Through continuous enhancements in its clinical programs, Siloam has achieved a 67% occupancy rate,
reflecting a 2.2% YoY increase, while maintaining 4,133 operational beds. The Company continues to
expand and optimize its Cardiology, Oncology, Neurology, Gastroenterology, and Orthopedics (CONGO)
programs, strengthening its service complexity.

Siloam continuously enhances revenue intensity by investing in healthcare innovations and expanding
revenue streams. As Indonesia’s first private hospital to adopt Da Vinci Xi robotic-assisted surgery, Siloam
is advancing minimally invasive procedures for complex cases in cardiology, thoracic surgery,
gastroenterology, gynecology, and urology.

Additionally, Siloam’s integrated Clinical Research Services (CRS) support the healthcare industry,
collaborating with over 30 CROs, academics, and sponsors. To enhance diagnostic accuracy, patient
experience, and operational efficiency, we have invested in AI for both front and back-office operations.
For example, Siloam’s AI-driven medical record management system features voice-to-text capability that
accelerates diagnoses and enhances patient care while optimizing expenditures.

Siloam has been recognized for its exceptional commitment to sustainability with a Bronze Medal from
EcoVadis, achieving a score of 64 out of 100 and ranking in the top 21% globally within its industry. This
remarkable achievement reflects an impressive 18-point improvement from the previous year. As part of
its ESG initiatives, Siloam is now an active member of the Indonesia Global Compact Network (IGCN) and
has obtained ISO 14001 for Environmental Management and ISO 45001 for Occupational Health & Safety.
In alignment with Indonesia's national commitment, Siloam is now dedicated to achieving net-zero
emissions by 2060, reinforcing its pledge through comprehensive measures, including environmental
policies, a code of conduct, sustainable procurement guidelines, and a well-defined decarbonization plan.
This recognition stands as a testament to Siloam’s ongoing pursuit of global sustainability excellence.

Remarks from Siloam’s President Director:

Siloam’s President Director, Mr. David Utama, commented on the results: “Siloam continues to
demonstrate strong and resilient growth throughout 2024, reflecting the successful implementation of its
strategic initiatives. With the launch of our Next Generation Siloam (NGS) strategy, we remain committed
to delivering outstanding patient care while enhancing hospital operations to ensure long-term financial
stability. As we prioritize operational excellence and advance our clinical programs, NGS will serve as a
catalyst for setting new benchmarks in healthcare excellence and driving sustainable growth for years to
come."
lain (radiasi, hormonal, sunti


For more information, please contact:

Vivian Chandra
Investor Relations
Siloam Hospitals Group
vivian.chandra@siloamhospitals.com


About Siloam Hospitals Group

PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed
to providing high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages
and operates 41 hospitals, consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the
islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also
operates 73 Siloam Clinics.

Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national
scale based on Godly compassion which is the basis for Siloam Hospitals to respond to the dynamic social
transformation in Indonesia. Siloam Hospitals' mission is to be the trusted choice for world-class holistic healthcare,
health education and research.

Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is
an international accreditation agency based in the United States that focuses on improving the quality of health
care and patient safety.

For more information about Siloam Hospitals, visit www.siloamhospitals.com.

Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not
intended for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is
given regarding the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our
opinions as of this date and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party
due to part or all of the contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not
responsible for any mistakes, omissions, omissions or inaccuracies that can happen.

Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain
words such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities
that are different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the
economic, social and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens
in Indonesia, including regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest
rate development, capital costs and capital availability; anticipated demand and supply prices related to our health services and related capital
expenditures and other investments; construction costs; availability of health services; competition from companies and other locations; changes
in customer demand; changes in operational costs, including employee salaries, wages and training, changes in public and government policies;
our ability to stay competitive; financial conditions, business strategies and plans and targets set by our management for future work;
procurement of future income; compliance with environmental and remediation regulations. If, among other things, one or more of the risks or
uncertainties mentioned above occur, the actual results may differ materially than predicted, anticipated or projected. In particular, but not
limited, capital costs can increase, projects can be postponed and anticipated increases in production, capacity or implementation may not all
occur. Although we believe that our management's expectations expressed in predictive statements are reasonable based on the information
we have at the moment, we cannot provide guarantees that these expectations can become reality. You should not depend on these statements
immediately. However, these statements apply only to the date they were stated, and we are not responsible for making updates or revisions,
even if new information, new events or anything is available.